Celgene Corp
update 05/24
122.58
-1.06 (-0.86%%)
TODAY
High 123.71
Low 121.66
Open 122.61
Volume 2286520
Time 05/24
52 WEEK SUMMARY
High 131.81
Low 58.53
P/E 29.69
Return
77.91%
Mkt Cap
51.131 B
Celgene Corporation is a global biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.
%7Cutmccn%3D(direct)%7Cutmcmd%3D(none);&utmn=238906024&utmp=%2Fquote%2FCELG%3AUS&utmhn=10.248.179.14&utmac=UA-11413116-12&utmhid=913340349)